Prophylactic Administration of Recombinant Human Thrombopoietin in the Secondary Prevention of Thrombocytopenia Induced by XELOX Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer

被引：3
|
作者：
Jin, Gaowa [1 ]
Wu, Yahan [2 ]
She, Zhanfei [3 ]
Ma, Xiaoyun [4 ]
Deng, Shuqin [1 ]
Wang, Wenjuan [1 ]
Wu, Yungaowa [1 ]
Li, Quanfu [1 ]
机构：
[1] Ordos Cent Hosp, Dept Med Oncol, Ordos, Peoples R China
[2] Peoples Hosp Inner Mongolia Autonomous Region, Dept Med Oncol, Hohhot, Peoples R China
[3] Ordos Cent Hosp, Dept Abdominal Surg, Ordos, Peoples R China
[4] Chifeng Cent Hosp, Dept Med Oncol, Chifeng, Peoples R China
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2021年 / 28卷 / 04期
关键词：
OXALIPLATIN;
D O I：
10.1097/MJT.0000000000001331
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：E513 / E516
页数：4
相关论文
共 50 条
  • [21] A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia
    Zhu, Qiuhua
    Yang, Shimei
    Zeng, Wenbin
    Li, Mingjie
    Guan, Zebing
    Zhou, Lanlan
    Wang, Hong
    Liu, Yanan
    Gao, Yanmin
    Qiu, Shiqiu
    Chen, Chaolun
    Li, Huan
    Zheng, Shanshan
    Yuan, Yuemei
    Zhang, Hanling
    Pan, Xueyi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] Adjuvant chemotherapy for stage III colon cancer patients
    Balakrishnan, L
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (11) : 1496 - 1496
  • [23] Randomized phase III trial of FOLFOX versus XELOX as adjuvant chemotherapy in patients with early-stage colorectal adenocarcinoma.
    Pectasides, Dimitrios G.
    Papaxoinis, George
    Xanthakis, Ioannis
    Kouvatseas, George
    Kotoula, Vassiliki
    Xiros, Nikolaos
    Samantas, Epaminondas
    Papakostas, Pavlos
    Klouvas, George
    Varthalitis, Ioannis I.
    Pentheroudakis, George E.
    Fountzilas, George
    Bafaloukos, Dimitris
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] The impact of adjuvant chemotherapy completion on prognosis of stage III colorectal cancer
    Nishimura, Junichi
    Takahashi, Yusuke
    Yasui, Masayoshi
    Asukai, Kei
    Yanagimoto, Yoshitomo
    Shinno, Naoki
    Sugimura, Keijiro
    Tomokuni, Akira
    Yamada, Daisaku
    Wada, Hiroshi
    Miyata, Hiroshi
    Ohue, Masayuki
    Yano, Masahiko
    CANCER SCIENCE, 2018, 109 : 1378 - 1378
  • [25] EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function
    Huang, Ching-Wen
    Chen, Yi-Ting
    Tsai, Hsiang-Lin
    Yeh, Yung-Sung
    Su, Wei-Chih
    Ma, Cheng-Jen
    Tsai, Tsen-Ni
    Wang, Jaw-Yuan
    ONCOTARGET, 2017, 8 (70) : 114663 - 114676
  • [26] The benefit of adjuvant chemotherapy in elderly patients with stage III colorectal cancer is independent of age and comorbidity
    Wildes, Tanya M.
    Kallogjeri, Dorina
    Powers, Brian
    Vlahiotis, Anna
    Mutch, Matthew
    Spitznagel, Edward L., Jr.
    Tan, Benjamin
    Piccirillo, Jay F.
    JOURNAL OF GERIATRIC ONCOLOGY, 2010, 1 (02) : 48 - 56
  • [27] Association of baseline patient characteristics with adjuvant chemotherapy toxicities in stage III colorectal cancer patients
    Watanabe, Akie
    Yang, Chang Cheng
    Cheung, Winson Y.
    MEDICAL ONCOLOGY, 2018, 35 (10)
  • [28] Impact of venous invasion on the efficacy of adjuvant chemotherapy in elderly patients with stage III colorectal cancer
    Nobuaki Hoshino
    Kenji Kawada
    Koya Hida
    Saori Goto
    Ryuji Uozumi
    Suguru Hasegawa
    Kenichi Sugihara
    Yoshiharu Sakai
    Medical Oncology, 2017, 34
  • [29] A prospective study of the geriatric assessment in elderly stage III colorectal cancer patients on adjuvant chemotherapy
    Okuno, Tatsuya
    Tei, Mitsuyoshi
    Yoshikawa, Yukihiro
    Nomura, Masatoshi
    Sueda, Toshinori
    Matsumura, Tae
    Miyagaki, Hiromichi
    Tsujie, Masanori
    Hasegawa, Junichi
    Akamaru, Yusuke
    ANNALS OF ONCOLOGY, 2022, 33 : S539 - S539
  • [30] Association of baseline patient characteristics with adjuvant chemotherapy toxicities in stage III colorectal cancer patients
    Akie Watanabe
    Chang Cheng Yang
    Winson Y. Cheung
    Medical Oncology, 2018, 35
12345